A, L., JC, G., & TC, J. (2026). NMR spectroscopic evidence that the antileishmanial drug sodium stibogluconate comprises one predominant molecular species. Journal of inorganic biochemistry, 278, 113237. https://doi.org/10.1016/j.jinorgbio.2026.113237
Chicago Style (17th ed.) CitationA, Lance-Byrne, Gee JC, and Johnstone TC. "NMR Spectroscopic Evidence That the Antileishmanial Drug Sodium Stibogluconate Comprises One Predominant Molecular Species." Journal of Inorganic Biochemistry 278 (2026): 113237. https://doi.org/10.1016/j.jinorgbio.2026.113237.
MLA (9th ed.) CitationA, Lance-Byrne, et al. "NMR Spectroscopic Evidence That the Antileishmanial Drug Sodium Stibogluconate Comprises One Predominant Molecular Species." Journal of Inorganic Biochemistry, vol. 278, 2026, p. 113237, https://doi.org/10.1016/j.jinorgbio.2026.113237.